Knockdown of LncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer Via Sponging MiR-1231
Overview
Affiliations
Background: Pancreatic cancer ranks first among the most aggressive malignancies. Long non-coding RNA (LncRNA) ABHD11-AS1 is known to be upregulated in pancreatic cancer. However, the mechanism by which ABHD11-AS1 mediates the tumorigenesis of pancreatic cancer remains unclear.
Methods: Gene and protein expressions in pancreatic cancer cells were detected by qRT-PCR and Western blot, respectively. Cell viability was measured by CCK-8 assay. Cell apoptosis and cycle were tested by flow cytometry. In addition, cell migration and invasion were tested by wound healing and transwell assay, respectively. The correlation between ABHD11-AS1, miR-1231 and cyclin E1 was confirmed by dual-luciferase report and RNA pull-down. Finally, xenograft mice model was established to investigate the role of ABDH-AS1 in pancreatic cancer in vivo.
Results: ABHD11-AS1 was found to be negatively correlated with the survival rate of patients with pancreatic cancer. ABHD11-AS1 silencing significantly inhibited the proliferation and induced the apoptosis of pancreatic cancer cells. Additionally, knockdown of ABHD11-AS1 greatly inhibited the migration and invasion of pancreatic cancer cells. Meanwhile, ABHD11-AS1 bound to miR-1231 and cyclin E1 was found to be the target of miR-1231. Moreover, ABHD11-AS1 knockdown-induced G1 arrest in pancreatic cancer cells was reversed by miR-1231 antagomir. Finally, knockdown of ABHD11-AS1 obviously inhibited the tumor growth of pancreatic cancer in vivo.
Conclusion: ABHD11-AS1 silencing significantly inhibited the tumorigenesis of pancreatic cancer in vitro and in vivo. Thus, ABHD11-AS1 may serve as a potential target for the treatment of pancreatic cancer.
Tan S, Li S, Xia L, Jiang X, Ren Z, Peng Q Int J Oncol. 2025; 66(3).
PMID: 39950321 PMC: 11844336. DOI: 10.3892/ijo.2025.5726.
induces autophagic and apoptotic cell death in pancreatic cancer cells.
El Mahi Y, Nizami Z, Wali A, Al Neyadi A, Magramane M, Al Azzani M Front Pharmacol. 2024; 15:1412565.
PMID: 39139643 PMC: 11319293. DOI: 10.3389/fphar.2024.1412565.
The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.
Pathania A, Chava H, Balusu R, Pasupulati A, Coulter D, Challagundla K Mol Ther Oncol. 2024; 32(2):200785.
PMID: 38595981 PMC: 10973673. DOI: 10.1016/j.omton.2024.200785.
Feng W, Lai Y, Wang J, Xu P Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(9):1485-1492.
PMID: 37814862 PMC: 10563104. DOI: 10.12122/j.issn.1673-4254.2023.09.05.
Huang G, Qiu Y, Fan Y, Liu J Neurochem Res. 2023; 49(1):85-98.
PMID: 37610605 DOI: 10.1007/s11064-023-04015-6.